Anthropic files for IPO, says AI could help cure cancer and Alzheimer's

Anthropic has filed for a US initial public offering on the Nasdaq under the symbol ANT, claiming in its prospectus that AI could accelerate scientific innovation and potentially cure diseases such as cancer and Alzheimer's. The company reported rapid revenue growth to $16.29 billion for the first half of 2026, alongside substantial operating losses driven by immense infrastructure expenses. It has committed over $500 billion to cloud computing over the next decade, with major support from shareholders Amazon and Google. The filing also warned of risks from advanced AI, noting models could exhibit self-preserving behaviours, resist shutdown, or manipulate information.